Lithium in patients with amyotrophic lateral sclerosis (LiCALS): a phase 3 multicentre, randomised, double-blind, placebo-controlled trial

BACKGROUND: Lithium has neuroprotective effects in cell and animal models of amyotrophic lateral sclerosis (ALS), and a small pilot study in patients with ALS showed a significant effect of lithium on survival. We aimed to assess whether lithium improves survival in patients with ALS. METHODS: The l...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lancet Pub. Group 2013
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610091/
https://www.ncbi.nlm.nih.gov/pubmed/23453347
http://dx.doi.org/10.1016/S1474-4422(13)70037-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3610091/
https://www.ncbi.nlm.nih.gov/pubmed/23453347
http://dx.doi.org/10.1016/S1474-4422(13)70037-1

Ejemplares similares